Zimmer Biomet Holdings, Inc. (ZBH) has a consensus analyst rating of Hold, based on 41 analysts covering the stock. Of those, 17 recommend buying, 21 recommend holding, and 3 recommend selling.
The analyst consensus price target for ZBH is $105.60, representing a +9.4% upside from the current price of $96.52. Price targets range from a low of $89.00 to a high of $122.00.
